Press Releases

BIRMINGHAM, Ala., Nov. 13, 2019 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced its plans to build a freestanding, 40-bed inpatient rehabilitation hospital in Toledo, Ohio near the intersection of Monroe Street and Secor Road.

ATLANTA and HOUSTON and WASHINGTON and WINSTON-SALEM, N.C., Nov. 13, 2019 /PRNewswire/ -- Javara and Privia Health, one of the nation's fastest growing primary care focused medical groups providing value-based care to its patients, are aligni

PHOENIX, Nov. 13, 2019 /PRNewswire/ -- Access to affordable pet vaccines and exams will now be more convenient than ever thanks to PetSmart's new expansion of its partnership with ShotVet®, a leading mobile vaccination provider.

SEATTLE, Nov. 13, 2019 /PRNewswire/ -- TransformativeMed, the leader in transforming electronic health records (EHRs) with apps directly embedded within the EHR, today announced a partners

ABBOTT PARK, Ill., Nov. 13, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that Miles D. White will be stepping down as Chief Executive Officer on March 31, 2020, after a remarkable 21-year tenure, the second longest for a non-founder in today's S&P 100. He will remain Executive Chairman of the Board. The Board has unanimousl

BOSTON, Nov. 13, 2019 /PRNewswire/ -- Chilmark Research's inaugural Healthcare Payer Ana

SOUTH SAN FRANCISCO, Calif., Nov. 13, 2019 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, is scheduled to present a company overview at the Jefferies 2019 London Healthcare Conference on Thursday, November 21, 2019 at

CRANBURY, N.J., Nov. 13, 2019 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, whose product candidates are targeted, receptor-specific therapeutics for the treatment of dis

HOUSTON, Nov. 13, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, announced it has begun preclinical testing of its drug candidate, WP1122, which it believes may present a new approach to treating highly gl

WESTON, Fla., Nov. 13, 2019 /PRNewswire/ -- ZyVersa Therapeutics, Inc. (ZyVersa),  a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, is pleased to announce that Stephen C. Glover, ZyVersa's Co-Founder, Chief Executive Officer, and President, is an